Sign in
4

Changes in Ownership

Jasper Therapeutics, Inc. Filed Acc 0001213900-23-088896

Director bought 30,000 shares at an average $0.61 ($18,240)

From the SEC's structured data for this filing

Trades in this filing

WIGGANS THOMAS G · Director

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2023-11-16 Purchase : show line 1 in the form +10,000 $0.60 $5,965 10,000 D
2023-11-17 Purchase : show line 2 in the form +10,000 $0.60 $5,966 20,000 D
2023-11-20 Purchase : show line 3 in the form +10,000 $0.63 $6,309 30,000 D
Open-market purchases · 30,000 sh · avg $0.61 · $18,240
Loading xslF345X05/ownership.xml…